BA
Bennicas & Associates Portfolio holdings
AUM
$173M
This Quarter Return
-7.39%
1 Year Return
+1.55%
3 Year Return
+40.3%
5 Year Return
+86.09%
10 Year Return
–
AUM
$145M
AUM Growth
–
Cap. Flow
+$145M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
91
New
91
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Procter & Gamble
PG
|
$15.2M |
| 2 |
Merck
MRK
|
$4.72M |
| 3 |
Sprott Physical Gold and Silver Trust
CEF
|
$4.37M |
| 4 |
Chevron
CVX
|
$4.22M |
| 5 |
Clorox
CLX
|
$3.92M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Staples | 18.72% |
| 2 | Healthcare | 14.02% |
| 3 | Materials | 13.27% |
| 4 | Energy | 8.56% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASA
26
ASA Gold and Precious Metals
ASA
$733M
| $2.1M | 1.45% |
+165,300
| New | +$2.1M |
|
27
Unilever
UL
$158B
| $2.03M | 1.4% |
+50,170
| New | +$2.03M |
|
28
Rayonier
RYN
$3.99B
| $2.02M | 1.39% |
+51,274
| New | +$2.02M |
|
29
GSK
GSK
$79.6B
| $1.97M | 1.36% |
+31,520
| New | +$1.97M |
|
30
Sanofi
SNY
$112B
| $1.93M | 1.34% |
+37,534
| New | +$1.93M |
|
31
PepsiCo
PEP
$203B
| $1.91M | 1.32% |
+23,367
| New | +$1.91M |
|
32
Bunge Global
BG
$16.4B
| $1.85M | 1.28% |
+26,134
| New | +$1.85M |
|
33
Eli Lilly
LLY
$667B
| $1.85M | 1.28% |
+37,660
| New | +$1.85M |
|
34
AbbVie
ABBV
$378B
| $1.76M | 1.21% |
+42,490
| New | +$1.76M |
|
35
Healthpeak Properties
DOC
$12.4B
| $1.7M | 1.17% |
+40,955
| New | +$1.7M |
|
36
RTX Corp
RTX
$212B
| $1.68M | 1.16% |
+28,635
| New | +$1.68M |
|
37
TotalEnergies
TTE
$134B
| $1.67M | 1.15% |
+34,300
| New | +$1.67M |
|
38
Verizon
VZ
$187B
| $1.67M | 1.15% |
+33,111
| New | +$1.67M |
|
|
ARMH
39
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $1.66M | 1.15% |
+45,800
| New | +$1.66M |
|
40
ConocoPhillips
COP
$119B
| $1.57M | 1.09% |
+25,970
| New | +$1.57M |
|
41
Copart
CPRT
$47.3B
| $1.53M | 1.06% |
+398,400
| New | +$1.53M |
|
42
IBM
IBM
$228B
| $1.53M | 1.06% |
+8,369
| New | +$1.53M |
|
43
Abbott
ABT
$232B
| $1.48M | 1.02% |
+42,510
| New | +$1.48M |
|
44
Pfizer
PFE
$140B
| $1.35M | 0.93% |
+50,814
| New | +$1.35M |
|
45
Pan American Silver
PAAS
$12.1B
| $1.28M | 0.89% |
+110,125
| New | +$1.28M |
|
|
CB
46
DELISTED
CHUBB CORPORATION
CB
| $1.27M | 0.88% |
+15,000
| New | +$1.27M |
|
47
DNP Select Income Fund
DNP
$3.67B
| $1.26M | 0.87% |
+127,934
| New | +$1.26M |
|
48
Annaly Capital Management
NLY
$14B
| $1.16M | 0.8% |
+22,975
| New | +$1.16M |
|
49
Freeport-McMoran
FCX
$65.5B
| $1.12M | 0.77% |
+40,368
| New | +$1.12M |
|
50
Equinor
EQNR
$60.4B
| $1.09M | 0.75% |
+52,500
| New | +$1.09M |
|